Skip to main content
OpenTrials

Clinical trial condition

Thrombotic Microangiopathies

Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.

404 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Thrombotic Microangiopathies trial results

Recruiting

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

NCT07710248

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Pingdingshan First People's Hospital Pingdingshan, Henan, China
  • Jining No.1 People's Hospital Jining, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View all 22 locations
View Trial Details
Recruiting

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT06948318

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 118 locations
View Trial Details
Recruiting

OM336 in Autoimmune Cytopenias

NCT07083960

Conditions
AIHA - Cold Autoimmune Hemolytic Anemia, AIHA - Warm Autoimmune Hemolytic Anemia, Anemia, +21 more
Locations
  • The Canberra Hospital Canberra, Australian Capital Territory, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • Icon Cancer Center South Brisbane Brisbane, Queensland, Australia
  • City of Hope Duarte, California, United States
View Trial Details
Recruiting

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

NCT06929299

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Roeselare, West-Vlaanderen, Belgium
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Dalian, Liaoning, China
View all 25 locations
View Trial Details
Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

NCT07007962

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates) Clovis, California, United States
  • University of Southern California (USC) Los Angeles, California, United States
  • Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011 New Orleans, Louisiana, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details

Related conditions